Dipartimento di Medicina Clinica e Scienze, Cardiovascolari ed Immunologiche, Cattedra di Geriatria, University of Naples Federico II, Naples, Italy.
Eur J Prev Cardiol. 2012 Dec;19(6):1401-9. doi: 10.1177/1741826711422991. Epub 2011 Sep 20.
Age-related effects on the ability of 6-min walking test (6MWT) and ejection fraction (EF) to predict mortality in coronary artery bypass grafting (CABG) patients undergoing cardiac rehabilitation (CR) is still debated.
In order to verify the role of 6MWT and EF on all-cause mortality in patients undergoing CR following CABG, 882 CABG patients undergoing CR stratified in adults (<65 years) and elderly (≥65 years) were studied.
At the admission, EF was 52.6 ± 9.1% in adults and 51.3 ± 8.9% in elderly (p = 0.234, NS) while 6MWT was 343.8 ± 93.5 m in adults and 258.9 ± 95.7 m in elderly (p < 0.001). After 42.9 ± 14.1 months follow up, mortality was 8.2% in adults and 10.9% in elderly (p = 0.176, NS). Cox regression analysis shows that EF ≥ 50% and 6MWT ≥300 m are protective on mortality in all CABG patients before CR. However, EF ≥50% in adults (HR 0.18, 95% CI 0.06-0.49, p < 0.005) but not in elderly (HR 1.16, 95% CI 0.45-3.42, p = 0.354, NS) and 6MWT ≥300 m in elderly (HR 0.34, 95% CI 0.10-0.79, p = 0.033) but not in adults (HR 0.76, 95% CI 0.31-2.12, p = 0.654, NS) exert a protective role on mortality.
Our results indicate that both EF ≥ 50% and 6MWT ≥ 300 m independently protect against mortality in CABG patients before CR. However, their protective role is age dependent. In fact, EF ≥ 50% is protective in adults but not in elderly while 6MWT ≥ 300 m is protective in elderly but not in adult patients.
年龄对 6 分钟步行试验(6MWT)和射血分数(EF)预测行心脏康复(CR)的冠状动脉旁路移植术(CABG)患者死亡率的能力的影响仍存在争议。
为了验证 6MWT 和 EF 在 CABG 后行 CR 的患者全因死亡率中的作用,对 882 名行 CR 的 CABG 患者进行了研究,这些患者分为成年人(<65 岁)和老年人(≥65 岁)。
在入院时,成年人的 EF 为 52.6±9.1%,老年人的 EF 为 51.3±8.9%(p=0.234,NS),而 6MWT 在成年人中为 343.8±93.5m,老年人中为 258.9±95.7m(p<0.001)。在 42.9±14.1 个月的随访后,成年人的死亡率为 8.2%,老年人的死亡率为 10.9%(p=0.176,NS)。Cox 回归分析显示,EF≥50%和 6MWT≥300m 是所有 CABG 患者在 CR 前的死亡率的保护因素。然而,EF≥50%在成年人中(HR 0.18,95%CI 0.06-0.49,p<0.005)但不在老年人中(HR 1.16,95%CI 0.45-3.42,p=0.354,NS)和 6MWT≥300m 在老年人中(HR 0.34,95%CI 0.10-0.79,p=0.033)但不在成年人中(HR 0.76,95%CI 0.31-2.12,p=0.654,NS)对死亡率有保护作用。
我们的结果表明,EF≥50%和 6MWT≥300m 均可独立降低 CABG 患者 CR 前的死亡率。然而,其保护作用是依赖于年龄的。实际上,EF≥50%在成年人中是保护因素,但在老年人中不是;而 6MWT≥300m 在老年人中是保护因素,但在成年人中不是。